Is Biocon Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Biocon Ltd (BIOCON.NS) is currently classified as NOT HALAL as of February 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Biocon Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Biocon Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Biocon Ltd?

Muslim investors may consider investing in Biocon Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Biocon Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of Biocon Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Biocon Ltd updated?

The Shariah compliance status of Biocon Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Biocon Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Biocon Ltd?

You can check the latest Shariah compliance status of Biocon Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

BIOCON.NS Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: February 13, 2026

Report Source: 2026 3rd Quarter Report

Biocon Ltd. Stock Analysis BIOCON.NS

India Health Care Mid Cap Report: Q3, 2026

Biocon Ltd. is a holding company, which engages in the manufacture, research, and development of therapeutic drugs. The firm is in the business of manufacturing active pharmaceutical ingredients (APIs) and formulations, including biosimilar drugs for diabetics, oncology and autoimmune diseases. The Company’s segment includes Generics, Biosimilars, Novel Biologics and Research Services. The company focuses on three key therapeutic areas - Oncology, Diabetes, and Immunology. Its APIs portfolio includes cardiovascular, anti-diabetics, immunosuppressants, and specialty molecules. Its products include Tacrolimus, Rosuvastatin, Simvastatin, Atorvastatin, Pravastatin, Fingolimod and others. Its APIs manufacturing facilities with capabilities in microbial fermentation, downstream process, including chromatographic purification, chemical synthesis, peptide synthesis and Highly Potent APIs (HPAPIs). The company has over five facilities in Bangalore, Hyderabad and Visakhapatnam in India.

Key Statistics of Biocon Ltd (BIOCON.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹417.30₹434.60

Today's Open

₹418.00

Volume

8.18M

P/E Ratio (TTM)

57.46

52 Week Range

₹313.00₹434.60

Market Cap

583.61B

Avg. Volume

4.79M

Dividend Yield

0.16%

Financial Metrics & Statements of Biocon Ltd (BIOCON.NS)

FAQ's for Biocon Ltd (BIOCON.NS)

According to Musaffa’s Shariah screening methodology, Biocon Ltd (BIOCON.NS) is currently classified as NOT HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.